Net Loss per Share

12 Months Ended

Dec. 31, 2023

13. Net Income (Loss) per Share

The following table sets forth the computation of the Company’s basic and diluted net income (loss) per share for the years ended December 31, 2023 and 2022 (in thousands, except share and per share amounts):


	Year Ended December 31,
	2023		2022
Numerator:
Net income (loss) attributable to common stockholders—basic and diluted	$	12,157	$	(105,890	)
Denominator:
Weighted-average common shares outstanding—basic		44,327,204		43,738,739
Effect of dilutive securities:
Options to purchase common shares		119,677		—
Unvested restricted stock units		95,010		—
Employee stock purchase plan		26,027		—
Weighted-average common shares outstanding—diluted		44,567,918		43,738,739

Net income (loss) per share applicable to common stockholders—basic	$	0.27	$	(2.42	)
Net income (loss) per share applicable to common stockholders—diluted	$	0.27	$	(2.42	)

Diluted earnings per share includes the assumed exercise of dilutive options, the assumed issuance of unvested restricted stock units, and the assumed issuance of shares under the employee stock purchase plan using the treasury stock method unless the effect is anti-dilutive. The treasury stock method assumes that proceeds, including cash received from the exercise of employee stock options and the average unrecognized compensation expense for unvested share-based compensation awards, would be used to purchase the Company’s common stock at the average market price during the period.

For the year ended December 31, 2022, for purposes of the diluted net income (loss) per share calculation, stock options, unvested restricted stock units are considered to be common stock equivalents but have been excluded from the calculation of diluted net loss per share, as their effect would be anti-dilutive for all periods presented. Therefore, the weighted-average number of common shares outstanding used to calculate both basic and diluted net income (loss) per share attributable to common stockholders is the same.

The following potentially dilutive common stock equivalents, presented based on amounts outstanding at each period end, were excluded from the computation of diluted net income (loss) per share attributable to common stockholders for the periods indicated:


	Year Ended December 31,
	2023		2022
Options to purchase common stock		3,765,482		9,423,271
Restricted stock units		662,103		940,392
Total anti-dilutive shares		4,427,585		10,363,663